GlassScriptPhysician profile
Katrina M Crader
NPI 1326304296
$14,875.40
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $3,297 · 2021: $9,933.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $6,865.51 | 2019-2021 | |
| Abbvie INC. | $5,321.39 | 2021 | |
| Vanda Pharmaceuticals INC. | $726.50 | 2019-2021 | |
| Indivior INC. | $264.78 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $260.14 | 2019-2021 | |
| Lundbeck LLC | $259.34 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $217.88 | 2019 | |
| Janssen Pharmaceuticals, INC | $175.84 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $169.96 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $149.03 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $115.99 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $95.21 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $58.86 | 2020-2021 | |
| Eisai INC. | $55.81 | 2020 | |
| Neuronetics, INC. | $39.35 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $30.47 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $27.13 | 2019 | |
| Orexo US, INC. | $16.84 | 2021 | |
| Adlon Therapeutics L.P. | $13.98 | 2020 | |
| Shire North American Group INC | $11.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Crader listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.